ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,396,000 | -66.4% | 1,300,000 | -42.1% | 0.00% | -70.0% |
| Q3 2021 | $57,737,000 | -1.5% | 2,246,576 | -0.0% | 0.01% | 0.0% |
| Q2 2021 | $58,591,000 | -26.1% | 2,246,577 | -0.0% | 0.01% | -33.3% |
| Q1 2021 | $79,305,000 | +32.5% | 2,246,603 | -5.3% | 0.02% | +25.0% |
| Q4 2020 | $59,865,000 | -40.4% | 2,371,817 | -11.0% | 0.01% | -45.5% |
| Q3 2020 | $100,523,000 | -32.6% | 2,665,686 | -23.4% | 0.02% | -38.9% |
| Q2 2020 | $149,062,000 | +157.5% | 3,481,124 | +16.9% | 0.04% | +111.8% |
| Q1 2020 | $57,886,000 | -25.2% | 2,977,664 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $77,360,000 | -13.4% | 2,977,664 | -9.1% | 0.02% | -22.7% |
| Q3 2019 | $89,279,000 | +19.8% | 3,275,685 | +18.1% | 0.02% | +29.4% |
| Q2 2019 | $74,497,000 | +18.7% | 2,774,581 | +27.8% | 0.02% | +13.3% |
| Q1 2019 | $62,778,000 | +7.4% | 2,171,483 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $58,478,000 | – | 2,171,483 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |